Form 4: Molina Healthcare Director Receives Equity Award

Sentiment:

Statement of Changes in Beneficial Ownership


Molina Healthcare, Inc. reports a director, Leo P. Grohowski, received an equity award of 405 shares of common stock on April 1, 2026, valued at $135.82 per share.

Summary

  • Leo P. Grohowski, a Director at Molina Healthcare, Inc., was granted 405 shares of common stock on April 1, 2026.
  • This grant is part of the Issuer's 2025 Equity Incentive Plan, awarded in connection with his services as a Director.
  • The annual equity award for directors is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
  • The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
  • On April 1, 2026, the closing price was $135.82, resulting in the 405-share grant.
  • Following this transaction, Mr. Grohowski beneficially owns 1,305 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine equity grant to a director as part of an established compensation plan, with no significant new financial information or strategic shifts.

Positives

  • Director Leo P. Grohowski received an equity award, indicating continued investment in and commitment to the company's leadership.
  • The award is part of a structured annual equity incentive plan, suggesting a consistent approach to director compensation.
  • The grant is based on the company's stock performance, aligning director incentives with shareholder value.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the ongoing equity incentive plan suggests a continued strategy of aligning director compensation with company performance.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare industry to ensure alignment between leadership and shareholder interests. The structure of Molina Healthcare's plan, with quarterly grants based on stock price, is a standard approach to incentivize long-term value creation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive PlanGrant of stock under the Issuer's 2025 Equity Incentive Plan.04/01/2026Reinforces alignment of director compensation with company performance and shareholder value.
Director Compensation StructureAnnual equity award for directors set at $220,000, with quarterly grants based on closing stock price.04/01/2026Standard practice to incentivize directors and ensure their interests are aligned with long-term company growth.

Stakeholder Impact

  • Shareholders: The equity award aligns director interests with shareholder value, potentially leading to decisions that benefit stock price.
  • Employees: The incentive structure for directors may indirectly influence company strategy, impacting employees.
  • Management: The award is part of the compensation structure for directors.

Next Steps

  • Continued quarterly equity grants to directors as per the 2025 Equity Incentive Plan.
  • Ongoing reporting of beneficial ownership changes for directors and officers.

Key Dates

DateDescription
03/28/2025Date of execution for the Limited Power of Attorney for Section 16(a) Filings by Leo Grohowski.
04/01/2026Transaction date for the grant of common stock to Leo P. Grohowski and the closing price of Molina Healthcare's common stock.
04/02/2026Date of signature for the Form 4 filing.

Keywords

Molina Healthcare, MOH, Form 4, Director, Equity Award, Stock Grant, Securities Exchange Act, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.